H. G. Alpermann

1.0k total citations · 1 hit paper
11 papers, 892 citations indexed

About

H. G. Alpermann is a scholar working on Genetics, Cancer Research and Pharmacology. According to data from OpenAlex, H. G. Alpermann has authored 11 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 3 papers in Cancer Research and 2 papers in Pharmacology. Recurrent topics in H. G. Alpermann's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Beetle Biology and Toxicology Studies (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). H. G. Alpermann is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Beetle Biology and Toxicology Studies (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). H. G. Alpermann collaborates with scholars based in Germany. H. G. Alpermann's co-authors include Klaus Wirth, Franz J. Hock, Bernward A. Schölkens, Udo Albus, Wilfried Α. König, Gerhard Breipohl, Jochen Knolle, Wolfgang Linz, Kay Brune and Hannes Vogel and has published in prestigious journals such as British Journal of Pharmacology, Cellular and Molecular Life Sciences and Naunyn-Schmiedeberg s Archives of Pharmacology.

In The Last Decade

H. G. Alpermann

11 papers receiving 841 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hoe 140 a new potent and long acting bradykinin‐antagonist:in vivostudies

1991 742 citations Klaus Wirth, Franz J. Hock et al. British Journal of Pharmacology profile →

Peers

Countries citing papers authored by H. G. Alpermann

Since Specialization

Citations

This map shows the geographic impact of H. G. Alpermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. G. Alpermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. G. Alpermann more than expected).

Fields of papers citing papers by H. G. Alpermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. G. Alpermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. G. Alpermann. The network helps show where H. G. Alpermann may publish in the future.

Co-authorship network of co-authors of H. G. Alpermann

This figure shows the co-authorship network connecting the top 25 collaborators of H. G. Alpermann. A scholar is included among the top collaborators of H. G. Alpermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. G. Alpermann. H. G. Alpermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	The bradykinin antagonist Hoe 140 inhibits carrageenan- and thermically induced paw oedema in rats. 1992 ·PubMed ·Klaus Wirth, H. G. Alpermann, (unknown), (unknown)	26
2	Pharmacological effects of Hoe 249: A new potential antidepressant 1992 ·Drug Development Research ·H. G. Alpermann, Ulrich Schacht, (unknown), Franz J. Hock	9
3	Hoe 140 a new potent and long acting bradykinin‐antagonist:in vivostudies breakdown → 1991 ·British Journal of Pharmacology ·Klaus Wirth, Franz J. Hock, Udo Albus, Wolfgang Linz, H. G. Alpermann, (unknown), (unknown), Gerhard Breipohl, Wilfried Α. König, Jochen Knolle, Bernward A. Schölkens	742
4	Influence of the new angiotensin converting enzyme inhibitor ramipril on several models of acute inflammation and the adjuvant arthritis in the rat. 1986 ·PubMed ·(unknown), H. G. Alpermann, R Schleyerbach	22
5	Central and Peripheral Action of Enkephalin Analogues 1983 ·Hoppe-Seyler´s Zeitschrift für physiologische Chemie ·Rolf Geiger, Martin Bickel, (unknown), H. G. Alpermann	4
6	Non-acidic pyrazoles: Inhibition of prostaglandin production, carrageenan oedema and yeast fever 1983 ·Inflammation Research ·Kay Brune, H. G. Alpermann	51
7	[Studies on the pharmacology and toxicology of ciclopiroxolamine (author's transl)]. 1981 ·PubMed ·H. G. Alpermann, (unknown)	19
8	Prevention of changes after UV-irradiation by sunscreen products in skin of hairless mice 1981 ·Archives of Dermatological Research ·Hannes Vogel, H. G. Alpermann, (unknown)	6
9	Effect of repeated ultraviolet irradiation on skin of hairless mice 1978 ·Archives of Dermatological Research ·H. G. Alpermann, Hannes Vogel	10
10	Über die Beeinflussung der Ca-Aufnahme in Lipidextrakte aus Mikrosomen und Mitochondrien des Herzens durch Digitoxin 1970 ·Cellular and Molecular Life Sciences ·H. G. Alpermann, (unknown), W. Klaus, R. Krebs	1
11	In vitro-Untersuchungen �ber den Einflu� von Digitoxin auf die Aufnahme von Calcium in Lipoidextrakte aus dem Herzmuskel 1969 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·W. Klaus, H. G. Alpermann, (unknown), R. Krebs	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact